Aquestive Therapeutics Inc (AQST)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Aquestive Therapeutics Inc-Aktie (AQST)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	1.62% 13.02	12.81	10.00	8.72	11.87
Cost Of Revenue	29.52% 5.836	4.506	4.561	3.652	4.52
Gross Profit	13.52% 7.179	8.301	5.442	5.068	7.347
Operating Expenses	82.09% 36.02	19.78	16.81	24.43	20.93
Benefits Costs and Expenses	58.83% 44.88	28.25	23.55	31.65	28.94
Costs And Expenses	72.34% 41.85	24.29	21.37	28.09	25.45
Depreciation and Amortization	6.47% 0.13	0.139	0.14	0.139	0.147
Operating Income/Loss	151.23% -28.84	-11.48	-11.37	-19.36	-13.58
Income/Loss From Continuing Operations Before Tax	106.27% -31.86	-15.45	-13.55	-22.93	-17.07
Income Tax Expense/Benefit	-	-	-	-	-0.014
Income/Loss From Continuing Operations After Tax	106.27% -31.86	-15.45	-13.55	-22.93	-17.05
Net Income/Loss	106.27% -31.86	-15.45	-13.55	-22.93	-17.05
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	95.42% 5.0686	110.58	99.33	95.50	1.5019
Diluted Average Shares	95.42% 5.0686	110.58	99.33	95.50	1.5019
Basic Earnings Per Share	92.86% -0.27	-0.14	-0.14	-0.24	-0.19
Diluted Earnings Per Share	92.86% -0.27	-0.14	-0.14	-0.24	-0.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ELAN

$22.94

1.15%

RGC

$23.23

3.21%

RDY

$14.13

1.53%

NBIX

$129.78

1.57%

VTRS

$13.51

2.10%

UTHR

$536.12

0.62%